{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:26:56Z","timestamp":1793276816559,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010842","name":"Temple University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010842","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.neo.2021.04.004","type":"journal-article","created":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T11:57:02Z","timestamp":1619870222000},"page":"529-538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2597-9441","authenticated-orcid":false,"given":"Noreen","family":"McBrearty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla","family":"Arzumanyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Bichenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0280-5289","authenticated-orcid":false,"given":"Salim","family":"Merali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4679-710X","authenticated-orcid":false,"given":"Carmen","family":"Merali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Feitelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2021.04.004_bib0001","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cld.2015.01.001","article-title":"Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability","volume":"19","author":"McGlynn","year":"2015","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.neo.2021.04.004_bib0002","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/hep.27222","article-title":"Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?","volume":"60","author":"El-Serag","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.neo.2021.04.004_bib0003","first-page":"141","article-title":"Update in global trends and aetiology of hepatocellular carcinoma","volume":"22","author":"Rawla","year":"2018","journal-title":"Contemp Oncol (Pozn)"},{"key":"10.1016\/j.neo.2021.04.004_bib0004","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11894-019-0681-x","article-title":"The epidemiology of hepatocellular carcinoma in the USA","volume":"21","author":"Kim","year":"2019","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.neo.2021.04.004_bib0005","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s40471-019-00188-3","article-title":"The changing epidemiology of primary liver cancer","volume":"6","author":"Petrick","year":"2019","journal-title":"Curr Epidemiol Rep"},{"key":"10.1016\/j.neo.2021.04.004_bib0006","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.neo.2021.04.004_bib0007","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.canlet.2008.12.010","article-title":"Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease","volume":"286","author":"Feitelson","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.neo.2021.04.004_bib0008","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2006.11.010","article-title":"Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis","volume":"252","author":"Feitelson","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.neo.2021.04.004_bib0009","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3449","article-title":"Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma","volume":"13","author":"Arzumanyan","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.neo.2021.04.004_bib0010","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1128\/MCB.00205-13","article-title":"Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis","volume":"33","author":"Tian","year":"2013","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.neo.2021.04.004_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13099-018-0281-6","article-title":"Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma","volume":"11","author":"Liu","year":"2019","journal-title":"Gut Pathog"},{"key":"10.1016\/j.neo.2021.04.004_bib0012","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0016-5085(00)70142-9","article-title":"The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line","volume":"118","author":"Inan","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neo.2021.04.004_bib0013","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1038\/cti.2016.29","article-title":"Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseases","volume":"5","author":"Richards","year":"2016","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.neo.2021.04.004_bib0014","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc3401","article-title":"Warburg behind the butyrate paradox?","volume":"12","author":"Burgess","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.neo.2021.04.004_bib0015","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3389\/fimmu.2015.00554","article-title":"Redirection of epithelial immune responses by short-chain fatty acids through inhibition of histone deacetylases","volume":"6","author":"Lin","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.neo.2021.04.004_bib0016","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1126\/science.1242674","article-title":"Feed your Tregs more fiber","volume":"341","author":"Bollrath","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.neo.2021.04.004_bib0017","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3748\/wjg.v7.i3.340","article-title":"Expression of nuclear factor-kappa B in hepatocellular carcinoma and its relation with the X protein of hepatitis B virus","volume":"7","author":"Guo","year":"2001","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.neo.2021.04.004_bib0018","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-\u03baB in the liver\u2013linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.neo.2021.04.004_bib0019","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbrc.2003.08.113","article-title":"Reactive oxygen species modulates the intracellular level of HBx viral oncoprotein","volume":"310","author":"Wang","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neo.2021.04.004_bib0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/hep.1840140106","article-title":"HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis","volume":"14","author":"Wang","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.neo.2021.04.004_bib0021","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11274-013-1499-6","article-title":"A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action","volume":"30","author":"Chong","year":"2014","journal-title":"World J Microbiol Biotechnol"},{"key":"10.1016\/j.neo.2021.04.004_bib0022","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1158\/0008-5472.CAN-12-2329","article-title":"Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein","volume":"72","author":"Arzumanyan","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2021.04.004_bib0023","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0168-8278(99)80172-X","article-title":"Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein","volume":"31","author":"Yu","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.neo.2021.04.004_bib0024","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.neo.2021.04.004_bib0025","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ijc.2910550409","article-title":"The value of hepatitis B x antigen as a prognostic marker in the development of hepatocellular carcinoma","volume":"55","author":"Zhu","year":"1993","journal-title":"Intl J Cancer"},{"key":"10.1016\/j.neo.2021.04.004_bib0026","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/sj.onc.1202470","article-title":"The translation initiation factor, hu-Sui1 may be a target of hepatitis B X antigen in hepatocarcinogenesis","volume":"18","author":"Lian","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2021.04.004_bib0027","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nmeth.2834","article-title":"Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells","volume":"11","author":"Kulak","year":"2014","journal-title":"Nat Methods"},{"key":"10.1016\/j.neo.2021.04.004_bib0028","doi-asserted-by":"crossref","first-page":"304re7","DOI":"10.1126\/scitranslmed.aac4765","article-title":"Excessive caloric intake acutely causes oxidative stress, GLUT4 carbonylation, and insulin resistance in healthy men","volume":"7","author":"Boden","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.neo.2021.04.004_bib0029","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1101\/gr.772403","article-title":"PANTHER: a library of protein families and subfamilies indexed by function","volume":"13","author":"Thomas","year":"2003","journal-title":"Genome Res"},{"key":"10.1016\/j.neo.2021.04.004_bib0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/15412555.2013.831063","article-title":"Analysis of the plasma proteome in COPD: Novel low abundance proteins reflect the severity of lung remodeling","volume":"11","author":"Merali","year":"2014","journal-title":"COPD"},{"key":"10.1016\/j.neo.2021.04.004_bib0031","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/rcm.6437","article-title":"Comparison of LTQ-Orbitrap Velos and Q-Exactive for proteomic analysis of 1-1000 ng RAW 264.7 cell lysate digests","volume":"27","author":"Sun","year":"2013","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.neo.2021.04.004_bib0032","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000342405","article-title":"Emerging signaling pathways in hepatocellular carcinoma","volume":"1","author":"Moeini","year":"2012","journal-title":"Liver Cancer"},{"key":"10.1016\/j.neo.2021.04.004_bib0033","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.3892\/ol.2016.5110","article-title":"The Ras\/Raf\/MEK\/ERK signaling pathway and its role in the occurrence and development of HCC","volume":"12","author":"Li","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.neo.2021.04.004_bib0034","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jhep.2009.03.028","article-title":"Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo","volume":"51","author":"Newell","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.neo.2021.04.004_bib0035","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1091\/mbc.e09-06-0455","article-title":"Ras and calcium signaling pathways converge at Raf1 via the Shoc2 scaffold protein","volume":"21","author":"Yoshiki","year":"2010","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.neo.2021.04.004_bib0036","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/mc.22946","article-title":"Butyrate inhibits HBV replication and HBV-induced hepatoma cell proliferation via modulating SIRT-1\/Ac-p53 regulatory axis","volume":"58","author":"Pant","year":"2019","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.neo.2021.04.004_bib0037","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ijc.2910480223","article-title":"Differentiating effect of sodium butyrate on human hepatoma cell lines PLC\/PRF\/5, HCC-M and HCC-T","volume":"48","author":"Saito","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1016\/j.neo.2021.04.004_bib0038","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1128\/JVI.02440-14","article-title":"The hepatitis B virus (HBV) HBx protein activates AKT to simultaneously regulate HBV replication and hepatocyte survival","volume":"89","author":"Rawat","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.neo.2021.04.004_bib0039","first-page":"6832","article-title":"Hepatitis B virus X protein maintains hepatic stellate cell activation by regulating peroxisome proliferator-activated receptor \u03b3","volume":"11","author":"Xu","year":"2018","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.neo.2021.04.004_bib0040","doi-asserted-by":"crossref","first-page":"e41931","DOI":"10.1371\/journal.pone.0041931","article-title":"Hepatitis B virus X protein upregulates mTOR signaling through IKK\u03b2 to increase cell proliferation and VEGF production in hepatocellular carcinoma","volume":"7","author":"Yen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2021.04.004_bib0041","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1038\/onc.2013.468","article-title":"Synergistic function of Kras mutation and HBx in initiation and progression of hepatocellular carcinoma in mice","volume":"33","author":"Ye","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2021.04.004_bib0042","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12953-017-0114-4","article-title":"Proteomic profiling of HBV infected liver biopsies with different fibrotic stages","volume":"15","author":"Katrinli","year":"2017","journal-title":"Proteome Science"},{"key":"10.1016\/j.neo.2021.04.004_bib0043","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2019.08.052","article-title":"Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma","volume":"179","author":"Gao","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.neo.2021.04.004_bib0044","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/1319-3767.37808","article-title":"Sorafenib in the treatment of advanced hepatocellular carcinoma","volume":"14","author":"Ben Mousa","year":"2008","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.neo.2021.04.004_bib0045","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1172\/JCI31457","article-title":"Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma","volume":"117","author":"Calvisi","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neo.2021.04.004_bib0046","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fcell.2016.00129","article-title":"Endocytosis and physiology: Insights from disabled-2 deficient mice","volume":"4","author":"Tao","year":"2016","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.neo.2021.04.004_bib0047","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1158\/0008-5472.CAN-04-3672","article-title":"Synergistic induction of DOC-2\/DAB2 gene expression in transitional cell carcinoma in the presence of GATA6 and histone deacetylase inhibitor","volume":"65","author":"Zhou","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2021.04.004_bib0048","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1172\/JCI36125","article-title":"Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter","volume":"120","author":"Hannigan","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neo.2021.04.004_bib0049","first-page":"1109","article-title":"Hepatitis B X antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma","volume":"8","author":"Feitelson","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2021.04.004_bib0050","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1128\/jvi.69.3.1851-1859.1995","article-title":"Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation","volume":"69","author":"Truant","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.neo.2021.04.004_bib0051","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13046-016-0290-6","article-title":"MicroRNA-106b is involved in transforming growth factor \u03b21\u2013induced cell migration by targeting disabled homolog 2 in cervical carcinoma","volume":"35","author":"Cheng","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.neo.2021.04.004_bib0052","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.3748\/wjg.v22.i22.5183","article-title":"miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma","volume":"22","author":"Yen","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.neo.2021.04.004_bib0053","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s12263-015-0500-4","article-title":"Influence of miRNA-106b and miRNA-135a on butyrate-regulated expression of p21 and cyclin D2 in human colon adenoma cells","volume":"10","author":"Schl\u00f6rmann","year":"2015","journal-title":"Genes Nutr"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558621000245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558621000245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:08:12Z","timestamp":1761484092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558621000245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1476558621000245"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2021.04.004","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2021.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}